The Centers for Medicare and Medicaid Services this week announced that they expect the average premium for a basic Medicare Part D prescription drug plan in 2016 to remain stable at about $32.50 per month.
In late July, the Government Accountability Office released a report on how the lack of effective communications between the Drug Enforcement Agency and both pharmaceutical distributors and chain pharmacy headquarters has impacted legitimate access to pain medicines. "The agency’s report further validates the need for bipartisan, bicameral legislation," according to NACDS.
The DEA announced on Tuesday that the 10th National Prescription Drug Take-Back will take place across the United States on Sept. 26 — except for in Pennsylvania and Delaware where the event will take place on Sept. 12.
Voters from all political parties support sunshine legislation that would make promote transparency in generic prescription drug payments by pharmacy benefit manager corporations, according to a national survey from the National Community Pharmacists Association released Tuesday.
The Israeli Health Ministry approved on Monday a decision to allow patients licensed to receive medical marijuana from a pharmacy with authorization from a medical expert, according to theJerusalem Post.
The Food and Drug Administration recently issued its final guidance on the appearance of generic pharmaceuticals, recommending that drugs made by generic manufacturers closely mimic the physical attributes, including the size, shape and color, of the drugs that they reference.
Congress, Medicare and industry stakeholders should strike the right balance to cut out fraud in the Medicare Part D drug program while preserving patient access to critical medications, the National Community Pharmacists Association stated in comments submitted in conjunction with a House Energy and Commerce subcommittee hearing Tuesday on the topic.
How hard is it to find $24 billion to offset the cost of repealing the medical device tax? As hard as it is “to find a cup of coffee at Starbucks.” That’s according to National Center for Policy Analysis senior fellow John R. Graham, in a Forbes commentary.
The Food and Drug Administration on Tuesday issued guidance indicating that the agency would give pharmacies an additional four months to comply with product tracing requirements scheduled to take effect July 1, 2015.
Pharmacy organizations have written a joint letter to the Food and Drug Administration asking officials to delay enforcement of a July 1 electronic product-tracing deadline for prescription drug dispensers.